Papargyri, N., Pontoppidan, M., Andersen, M. R., Koch, T., & Hagedorn, P. H. (2019). Chemical Diversity of Locked Nucleic Acid-Modified Antisense Oligonucleotides Allows Optimization of Pharmaceutical Properties. Mol Ther Nucleic Acids.
Chicago Style CitationPapargyri, Natalia, Malene Pontoppidan, Mikael R. Andersen, Troels Koch, i Peter H. Hagedorn. "Chemical Diversity of Locked Nucleic Acid-Modified Antisense Oligonucleotides Allows Optimization of Pharmaceutical Properties." Mol Ther Nucleic Acids 2019.
Cita MLAPapargyri, Natalia, et al. "Chemical Diversity of Locked Nucleic Acid-Modified Antisense Oligonucleotides Allows Optimization of Pharmaceutical Properties." Mol Ther Nucleic Acids 2019.
Atenció: Aquestes cites poden no estar 100% correctes.